PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Pivmecillinam→

Pivmecillinam PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
32886-97-8
Molecular formula
C21H33N3O5S
Molecular weight
439.57 g/mol
Drug class
Amidinopenicillin beta-lactam antibacterialoral prodrug of mecillinam
Mechanism of action
Pivmecillinam is rapidly hydrolysed to mecillinam, which inhibits bacterial cell-wall biosynthesis by preferentially binding penicillin-binding protein 2 (PBP-2) in Gram-negative bacteria.
Indications / reported uses
  • Treatment of uncomplicated urinary tract infections in adult women caused by susceptible Escherichia coli, Proteus mirabilis or Staphylococcus saprophyticus, under the current product label.

Sources: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=440a5f17-ab11-0fc8-e063-6394a90a58e9&type=display · https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-uncomplicated-urinary-tract-infections · DailyMed

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Pivmecillinam PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Pivmecillinam Permitted Daily Exposure (PDE) report (the Pivmecillinam PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Pivmecillinam Occupational Exposure Limit (OEL) report (the Pivmecillinam OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.